Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BLUE
Recent news which mentions BLUE
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Moderna (MRNA) Stock Pops on RSV Vaccine Trial Results
January 18, 2023
Tickers
BLUE
FUV
MRNA
RDN
Tags
FUV
Market News
BLUE
From
InvestorPlace
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
January 18, 2023
Tickers
BLUE
MRNA
Tags
^IXIC
BLUE
Recent Press Releases
From
Motley Fool
Why is Bluebird Bio (BLUE) Stock Down 9% Today?
January 18, 2023
Tickers
BLUE
FFIE
FUV
GS
Tags
FFIE
Today's Market
NASDAQ:BLUE,NYSE:GS,NYSE:JPM,NASDAQ:FUV,NYSE:RDN,NASDAQ:FFIE
From
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 18, 2023
Tickers
ATXI
BLUE
CLXT
CYTH
Tags
OTRKP
BLUE
ATXI
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 18, 2023
Tickers
ARBK
ATXI
BLUE
BTCM
Tags
ORGS
POET
FUV
From
InvestorPlace
2 Stocks That Could Double Your Money in 2023
January 07, 2023
Tickers
AXSM
BLUE
Tags
AXSM
Recent Press Releases
Market News
From
Motley Fool
Newly Approved Drugs In US Command Over $200,000 On An Average
January 05, 2023
Tickers
BLUE
QURE
Tags
Benzinga
General
News
From
Benzinga
1 Cathie Wood Stock to Buy While It's Affordable, and 1 to Avoid (for Now)
December 30, 2022
Tickers
ARKK
BLUE
CRSP
NTLA
Tags
NTLA
ARKK
BLUE
From
Motley Fool
After Doubling in the Past 6 Months, Is This Stock a Buy?
December 24, 2022
Tickers
BLUE
CRSP
VRTX
Tags
BLUE
CRSP
Recent Press Releases
From
Motley Fool
FDA Allows Bluebird Bio To Resume Sickle Cell Disease Studies In Patients Below 18, With Changed Protocol
December 19, 2022
Tickers
BLUE
Tags
Health Care
Briefs
News
From
Benzinga
BLUE Stock Alert: What to Know as the FDA Lifts Hold on Bluebird Bio Treatment
December 19, 2022
Tickers
BLUE
Tags
BLUE
Market News
NASDAQ:BLUE
From
InvestorPlace
Magenta Therapeutics Shares Surge After Encouraging Data From Blood Cancer Candidate At ASH Meeting
December 13, 2022
Tickers
BLUE
MGTA
Tags
News
Briefs
General
From
Benzinga
Why Bluebird Bio Stock Crushed the Market Today
December 12, 2022
Tickers
BLUE
Tags
Market News
Recent Press Releases
BLUE
From
Motley Fool
2 Risky Stocks That Could Soar in 2023
December 06, 2022
Tickers
BLUE
KRYS
Tags
KRYS
BLUE
Recent Press Releases
From
Motley Fool
Looking Into bluebird bio's Return On Capital Employed
November 30, 2022
Tickers
BLUE
Tags
Market News
BLUE
BZI/ROCE
From
Benzinga
Bluebird Bio Sells Priority Review Voucher For $102M, Strengthening Its Financial Position
November 30, 2022
Tickers
ARGX
BLUE
Tags
News
Briefs
General
From
Benzinga
FDA Approves UniQure's Hemgenix, First Hemophilia B Gene Therapy For Adults
November 23, 2022
Tickers
BLUE
CSLLY
QURE
Tags
Eurasia
BLUE
Market News
From
Benzinga
Where Will Editas Medicine Be in 1 Year?
November 20, 2022
Tickers
BLUE
CRSP
EDIT
Tags
EDIT
Recent Press Releases
Market News
From
Motley Fool
2 Growth Stocks That Could Double in 2023
November 17, 2022
Tickers
BLUE
CRSP
VRTX
Tags
VRTX
BLUE
CRSP
From
Motley Fool
Analyst Ratings for bluebird bio
November 08, 2022
Tickers
BLUE
Tags
Benzinga
BZI/AAR
Analyst Ratings
From
Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
November 08, 2022
Tickers
ACMR
ACOR
ADPT
AFMD
Tags
AMRN
SPR
RDFN
From
Benzinga
Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday
November 08, 2022
Tickers
ACMR
AMG
BLUE
BTU
Tags
BLUE
DWAC
SYNH
From
Benzinga
Recap: bluebird bio Q3 Earnings
November 07, 2022
Tickers
BLUE
Tags
Benzinga
Earnings
BZI/Recaps
From
Benzinga
Better Buy: CRISPR Therapeutics vs. Bluebird Bio
October 27, 2022
Tickers
BLUE
CRSP
Tags
CRSP
BLUE
Recent Press Releases
From
Motley Fool
What's Next For Cell Therapy In Oncology? Enlivex (NASDAQ: ENLV) Says It Has The Answers
October 25, 2022
Tickers
BLUE
ENLV
FATE
NKTX
Tags
Benzinga
General
Enlivex Therapeutics
From
Benzinga
Why Legend Biotech's Shares Jumped 14.2% On Tuesday
October 18, 2022
Tickers
BLUE
BMY
JNJ
LEGN
Tags
JNJ
LEGN
Market News
From
Motley Fool
Should You Buy the Dip With Bluebird Bio?
October 04, 2022
Tickers
BLUE
Tags
Market News
Recent Press Releases
BLUE
From
Motley Fool
Bluebird Bio Offers World's Most Expensive Drugs, But Uncertainty Looms Over Its Financial Future
October 03, 2022
Tickers
BLUE
CRSP
VRTX
Tags
BLUE
Biotech
Market News
From
Benzinga
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
October 03, 2022
Tickers
AAN
AEHL
AEI
AIMD
Tags
Movers
RDIB
MOND
From
Benzinga
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
October 02, 2022
Tickers
ALNY
AMLX
AZN
BLUE
Tags
Top Stories
IBB
SCPH
From
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.